BDH INDUSTRIES LTD.

BDH Industries Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain shut from October 1st, 2026, until 48 hours after the declaration of the standalone un-audited financial results for the second quarter and half-year ended September 30th, 2026. The exact date for the Board of Directors meeting to consider these financial results will be communicated separately. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.

BDH Industries Ltd announced its Standalone Unaudited Financial Results for the first quarter ended June 30, 2026. The Board of Directors approved these results on August 14, 2026. A limited review report from statutory auditors M/s. CLB & Associates was also approved. The results will be published in newspapers as per SEBI regulations. The company operates in the Pharmaceuticals and Renewable Energy segments.

BDH Industries Ltd announced that its Board of Directors has approved the Standalone Unaudited Financial Results for the first quarter ended June 30, 2026. The results were reviewed by the Audit Committee and approved by the Board on August 14, 2026. The company also noted that the Statutory Auditors have completed a limited review with an unmodified conclusion. The financial results are scheduled for publication in newspapers as per SEBI regulations. The company's operations span Pharmaceuticals and Renewable Energy.

BDH Industries Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda item for this meeting is to consider and approve the standalone unaudited financial results for the first quarter ended June 30, 2026, of the financial year 2026-2027. Additionally, the company has informed about the closure of the trading window for its securities from July 1, 2026, until August 18, 2026, in compliance with SEBI regulations regarding insider trading.

BDH Industries Ltd has announced Friday, August 7, 2026, as the record date for determining shareholder entitlement to a dividend, subject to approval at the 36th Annual General Meeting (AGM). The AGM is scheduled for Friday, August 14, 2026, to be held via video conferencing. The proposed dividend is ₹5 per equity share of face value ₹10, for the financial year ended March 31, 2026. Shareholders whose names appear on the company's register on the record date will be eligible for this dividend if sanctioned by the AGM.

BDH Industries Ltd. has filed its Annual Report for the financial year 2025-26 and the Notice for its 36th Annual General Meeting (AGM). The AGM is scheduled for Friday, August 14, 2026, at 3:00 p.m. and will be conducted entirely through Video Conferencing (VC) / Other Audio Visual Means (OVAM). Key agenda items include the adoption of audited financial statements, declaration of dividend, re-appointment of a director, and ratification of cost auditors' remuneration for FY 2026-27. The company also provided its vision and quality policy, emphasizing affordable and quality medicines globally.

BDH Industries Ltd has announced its 36th Annual General Meeting (AGM) will be held on Friday, August 14, 2026, at 3:00 p.m. through Video Conferencing (VC) / Other Audio Visual Means (OVAM). The meeting will transact business as set out in the notice, including the recommendation of a dividend of ₹5 per equity share for the financial year ended March 31, 2026. The record date for determining eligibility for this dividend is August 7, 2026. Members can participate and vote electronically via NSDL's platform from August 11 to August 13, 2026. The Annual Report for FY2025-26 is available on the company's website and NSDL's e-voting portal.

BDH Industries Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will remain shut from July 1st, 2026, until 48 hours after the declaration of the standalone un-audited financial results for the first quarter ended June 30th, 2026. The date of the board meeting to approve these results will be communicated separately. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.

BDH Industries Ltd's board approved audited standalone financial results for Q4 and FY26, recommending a dividend of ₹5 per equity share, subject to shareholder approval at the 36th AGM. The AGM will be held on August 14, 2026, via video conferencing. The board also recommended the reappointment of Ms. Karthika Nair as a Director and appointed Chhajed Kedia & Associates as Internal Auditors and Krishna S. & Associates as Cost Auditors for FY 2026-27.

BDH Industries Ltd's Board of Directors approved the audited standalone financial results for the fourth quarter and year ended March 31, 2026. The board recommended a dividend of ₹5 per equity share of face value ₹10 each, subject to shareholder approval. The 36th Annual General Meeting will be held on August 14, 2026, via video conferencing. The board also recommended the appointment of Ms. Karthika Nair as Director and appointed Chhajed Kedia & Associates as Internal Auditors and Krishna S. & Associates as Cost Auditors for FY 2026-27.